The final examination and acceptance of NCPC New Drug R$D Co., Ltd's immunosuppressant drug high-tech demonstration project was finished recently. The project is to realize the industrial production of immunosuppressant drugs adopting microbial fermentation and other bio-technologies. Now the company owns the production capacities of 15kg Sirolimus and 8.4 ton Mycophenolate Mofetil.